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Abstract
Introduction: Significant physical sequelae exist for some survivors of a critical illness. There are, however, few
studies that have examined specific interventions to improve their recovery, and none have tested a home-based
physical rehabilitation program incorporating trainer visits to participants’ homes. This study was designed to test
the effect of an individualised eight-week home-based physical rehabilitation program on recovery.
Methods: A multi-centre randomised controlled trial design was used. Adult intensive care patients (length of stay
of at least 48 hours and mechanically ventilated for 24 hours or more) were recruited from 12 Australian hospitals
between 2005 and 2008. Graded, individualised endurance and strength training intervention was prescribed over
eight weeks, with three physical trainer home visits, four follow-up phone calls, and supported by a printed
exercise manual. The main outcome measures were blinded assessments of physical function; SF-36 physical
function (PF) scale and six-minute walk test (6MWT), and health-related quality of life (SF-36) conducted at 1, 8 and
26 weeks after hospital discharge.
Results: Of the 195 participants randomised, 183, 173 and 161 completed the 1, 8 and 26 weeks assessments,
respectively. Study groups were similar at Week 1 post-hospital; for the intervention and control groups
respectively, mean norm-based PF scores were 27 and 29 and the 6MWT distance was 291 and 324 metres. Both
groups experienced significant and clinically important improvements in PF scores and 6MWT distance at 8 weeks,
which persisted at 26 weeks. Mixed model analysis showed no significant group effects (P = 0.84) or group by time
interactions (P = 0.68) for PF. Similar results were found for 6MWT and the SF-36 summary scores.
Conclusions: This individualised eight-week home-based physical rehabilitation program did not increase the
underlying rate of recovery in this sample, with both groups of critically ill survivors improving their physical
function over the 26 weeks of follow-up. Further research should explore improving effectiveness of the
intervention by increasing exercise intensity and frequency, and identifying individuals who would benefit most
from this intervention.
Trial registration: Australia and New Zealand Clinical Trials Register ACTRN12605000166673
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A critical illness requiring admission to a general inten-
sive care unit (ICU) affects approximately 119,000 adult
Australians per year [1]. While survival rates approxi-
mate 89% at hospital discharge [2], functional recovery
for individuals is delayed often beyond six months post-
discharge [3,4]. Physical de-conditioning and neuromus-
cular dysfunction [5,6] as well as psychological sequelae
[7] are common, adding to the burden of illness for sur-
vivors, carers, the health care system and broader
society [8].
Reviews of numerous observational studies confirm
delayed recovery in health-related quality of life
(HRQOL), [for example, 3, 4, 9] and anxiety (12-43%)
[10], depression (median 28%) [11] and distress (includ-
ing post-traumatic stress symptoms; 5-64%) [12] are
prevalent. While significant sequelae therefore exist for
a substantial proportion of critical illness survivors, little
evidence is currently available to support specific inter-
ventions for improving their recovery [8,13], with very
few published interventional studies focusing on the
post-hospital discharge period; for example, follow-up
clinics [14], a patient self-managed rehabilitation manual
[15]. No studies have tested the effects of home-based
rehabilitation involving trainer visits on patient recovery.
We proposed that a focused home-based approach to
physical rehabilitation in addition to usual community-
based health services, would improve the HRQOL and
recovery of individuals surviving a critical illness. The
rehabilitation program for this cohort reflected similar
successful programs in cardiac and respiratory disease
[16,17] by optimising functional recovery, particularly
during the first few months after a critical illness.
Materials and methods
Design, hypothesis and secondary aims
A multi-centre randomised controlled trial (RCT) design
was used to test the effects of an eight-week home-
based rehabilitation program on HRQOL and physical
function for individuals who survived a critical illness.
The primary research hypothesis was: Survivors of a cri-
tical illness who participated in the physical rehabilita-
tion program have better physical function, as measured
by a difference of 10 points on the Physical Functioning
(PF) scale of the Short-Form-36 Health Survey (SF-36),
when compared to those who received usual care at
eight weeks after hospital discharge (short-term effect);
and that this group difference would persist at 26 weeks
(long-term effect). Secondary aims were to test the pro-
gram effectiveness for: improvement in other domains
of HRQOL (Component Summary scores of SF-36 [18]);
and better functional exercise capacity, measured by the
six-minute walk test (6MWT) [19].
The study protocol was published previously [20] and
the flow of participants reflects the CONSORT state-
ment [21]. Human Research Ethics Committee
approvals were obtained from each of the recruitment
site hospitals and the universities of the investigators. A
safety protocol ensured assessor and trainer safety dur-
ing home visits [20].
Participants and sample size
Participants were initially recruited from ICUs in Sydney
and Brisbane (from four teaching and three district hos-
pitals) with other recruitment sites added progressively
from Sydney and Perth (two teaching, two district and
one private hospital). Sample size was calculated for the
SF-36 PF scale for a two-sided hypothesis test with a
Type I error rate of 0.05 and a Type II error rate of 0.20
(80% power). The clinically important difference and the
standard deviation estimates used were based on our
pilot data [22,23] and reports for similar cohorts and
contexts [15,24-26].
At baseline (one week post-hospital discharge), we
anticipated that both groups would have mean PF scores
of 45. We postulated that the control group would
improve by 5 points at eight weeks, with the intervention
group improving by 15 points, giving a difference of 10
points between the two study groups using the traditional
non-normalised raw score for SF-36. Using the 10 items
that comprise the PF scale of SF-36, this improvement
represents a change from ‘limited a lot’ to ‘limited a little’
on three items in the scale, for example in climbing stairs
or walking particular distances. These changes reflect sig-
nificant clinical improvement in physical function [27].
A sample of 100 patients per study group was
required to detect this difference, assuming similar
group variance (SD = 25) [22,28]. We planned to over-
enrol by 20% to account for losses to follow-up (10%
study attrition [15]; 10% mortality at six-months post-
hospital discharge following a critical illness) [1,29]. The
total planned recruitment was therefore 240.
To be eligible for enrolment, participants: 1) were
aged 18 years or older; 2) had an ICU length of stay
(LOS) of ≥48 hours; 3) received mechanical ventilation
for ≥24 hours; 4) were discharged home to self-care or
carer (non-institutional care); 5) resided within the hos-
pitals’ local geographical areas to enable home visits (an
approximately 50 km radius); 6) had no neurological,
spinal or skeletal dysfunction preventing participation in
physical rehabilitation; 7) were not receiving palliative
care; 8) had no organised rehabilitation related to
ongoing chronic disease management (for example, pul-
monary rehabilitation, cardiac rehabilitation); and 9)
were cognitively able to complete the self-report mea-
sures and comply with physical testing instructions.
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Eligible patients were approached following ICU dis-
charge; informed voluntary consent was either obtained
at that time or following agreement to be contacted at
home after hospital discharge. After participant consent,
the site project officer contacted an independent tele-
phone randomisation service for the participant study
number and group allocation. The service used a
blocked random allocation sequences (one for each
recruitment site) generated using SAS software [30] by
our study statistician (MK).
Intervention
Participants in the control group received usual commu-
nity-based care after hospital discharge (for example,
visits to their general practiti o n e r ) ,a sw e l la st h et h r e e
study assessment visits, but no other placebo or sham
interventions. Following the first home-based assess-
ment, participants randomised to the intervention group
received an eight-week home-based physical rehabilita-
t i o np r o g r a mt h a tf o c u s e do ns t r e n g t ht r a i n i n ga n d
walking. A qualified trainer (physiotherapist, exercise
physiologist or registered nurse with additional specific
training for this project) visited participants at home in
weeks 1, 3 and 6 to provide individualised verbal and
written instructions on their planned exercise program.
Each home visit session was 60 to 90 minutes in dura-
tion. The trainer also telephoned intervention group
participants in weeks 2, 4, 5 and 7 to monitor their
progress.
The program reflected standard approaches for
improving muscle strength and endurance within car-
diac and pulmonary rehabilitation settings [31,32]. Exer-
cise prescription and supervised physical rehabilitation
training involved graded, individualised endurance and
strength training designed by a pulmonary rehabilitation
physiotherapist. Training focused initially on walking
(endurance training) and lower limb exercises (strength
training). As participants progressed, core stabilisation
and upper limb exercises were introduced. The remain-
ing two trainer home visits and telephone contacts in
non-visit weeks assessed participant progress and com-
pliance, prescribed progression and reinforced the exer-
cise program [20].
An illustrated exercise manual supported the partici-
pant’s training and graded progression, structured in
three parts: Part 1 described how to gauge exercise
intensity based on a level of ‘moderate’ to ‘somewhat
heavy’ perceived exertion (score of 3 to 4 on the modi-
fied Borg Scale) [33] and also provided information
about participant safety; Part 2 provided a detailed exer-
cise program; and Part 3 described how to progress the
endurance and strength training. The exercise program
consisted of five components-endurance exercise
(walking), lower and upper limb strengthening, core sta-
bilisation, flexibility, and stretches. A total of 16 differ-
ent exercises were numbered, named, illustrated and
described, to facilitate participant-trainer communica-
t i o na n de x e r c i s ep r o g r e s s i o n .T h i si n c l u d e df o u r
stretching, three flexion, and three core stabilisation
exercises, which were included in the trainer’se x e r c i s e
prescription based on assessment of the participant’s
capabilities and needs.
Endurance (walk) training
Exercise prescription for endurance training was based
on the results of each participant’s6 M W Td u r i n gt h e
Week 1 assessment visit. Training intensity commenced
at 80% of peak walking speed. Extra activities were pre-
scribed based on a level of perceived exertion of 3 to 4
using the modified Borg scale [33]. A walk-rest-walk
approach was used, with the duration of walking varying
according to the participant’s ability and condition; 12
levels of walking were described ranging from 1 to 60
minutes. Participants worked towards an optimal goal of
training for five days per week for 20 to 30 minutes of
walking by the end of the program.
Strength training
This training included upper (biceps, triceps, shoulder
abductors/adductors) and lower limb (quadriceps, ham-
strings, hip abductors and extensors) muscle groups.
Initial prescription was one set of eight-repetition maxi-
mum (8RM) for each activity, progressing to three sets.
Further progression was based on increasing weight
(0.25 to 1.5 kg for arm exercises using cans of food or
bags of rice), and increasing the step height or weight
for lower limb exercises. Levels of progression were
described in the exercise manual.
Outcomes
Each participant was assessed in-home within one week
of hospital discharge by an assessor blind to group allo-
cation, with follow-up assessments at 8 and 26 weeks
post-discharge. The primary outcome measure was the
physical functioning of study participants, using the SF-
36 PF scale (version 2) [18]. SF-36 has demonstrated
reliability, validity and responsiveness in the post-ICU
population [34], and is the most common instrument
used for assessing health status in this patient cohort
[3,4,8,9].
Secondary outcome measures were exercise capacity
measured using the 6MWT [19]; and HRQOL. The
6MWT was performed twice at each assessment, to
account for any learning effect, with the best result
recorded for analysis. During the 6MWT, participants
were directly observed and monitored continuously by
the assessor using a portable pulse oximeter (measuring
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level assessed and documented during the test [19]
using the Borg perceived exertion scale [33]. Additional
aspects of HRQOL were measured using the Physical
Component Summary (PCS) and Mental Component
Summary (MCS) scales, which combine information
from all eight domains of SF-36 [18].
Statistical methods
Data were entered into a purpose-built MS Access data-
base at the three coordinating sites; monthly site reports
on enrolment, randomisation and participant follow-up
were submitted to one central site and monthly summa-
ries of the whole cohort reviewed by our team. Analysis
was by intention-to-treat, and was conducted for the
primary outcome (SF-36 physical functioning; PF) and
three secondary outcomes, the 6MWT distance, the
physical component summary (PCS) and the mental
component summary (MCS) scores of SF-36. The SF-36
scales (PF, PCS and MCS) were calculated as per the
user’s manual [18]. The eight raw domain scores were
transformed to a score range of 0 to 100 (a higher score
represents better functioning/HRQOL). Domain scores
were then further summarised into PCS and MCS
scores using z-scores with each domain mean and stan-
dard deviation derived from Australian normative data
[35,36]. The component aggregate score was calculated
by summing the weighted z-scores using factor score
coefficients from normative population data as weight.
The aggregate component scores and the PF domain z-
score were then converted to norm-based scores (NBS)
as: NBS = 50 + (z-score × 10) [36]. Norm-based scores
are interpreted in relation to the population mean of 50
and a standard deviation of 10. Baseline characteristics
of both groups were described in terms of percentages
for categorical variables and mean and standard devia-
tion for continuous variables.
Study hypotheses were tested with mixed linear
regression models estimated by residual maximum like-
lihood using SAS Proc Mixed [30]. Fixed effects were
estimated for randomisation group (to test for differ-
ences between groups at eight weeks), time (to test for
change from 8 to 26 weeks), and a group by time inter-
action (to test for differences in change by group), with
the baseline level of the outcome variable included as a
covariate. Each model included a random person speci-
fic intercept to account for within person correlation.
Patient characteristics considered to be potential con-
founders (age, gender, APACHE II scores, days in ICU,
days in hospital) and site were included as covariates.
Covariates were retained if: 1) there was evidence of
confounding (estimates of treatment effect differed
markedly between adjusted versus unadjusted models);
2) they explained significant variation in the outcome; 3)
they improved the precision of the estimates of treat-
ment effect. The F-test was used to test for the signifi-
cance of effects and the adjusted mean levels of each
outcome variable were calculated for each group at 8
and 26 weeks (adjusted for baseline levels). As a second-
ary descriptive analysis, individual change scores were
calculated between baseline (Week 1 post-hospital dis-
charge) and at 8 and 26 weeks. Within-group effect size
was calculated as mean change from baseline/standard
deviation at baseline, and between-group effect size was
calculated as the difference between groups in mean
change from baseline divided by the pooled standard
deviation for change [37].
Results
Study recruitment occurred from June 2005 to August
2008, with final follow-up data collection completed in
February 2009. Of the 5,980 patients screened, 5,655
were excluded; the main reasons were excessive distance
from the study sites precluding home visits, neurological
or spinal dysfunction precluding physical training, and
palliative care/not expected to survive ICU admission
(Figure 1). Of the 195 patients randomised during their
post-ICU hospitalisation, 93% provided primary out-
come data at week 1 post-hospital discharge. Their sub-
sequent response rate was 95% (97% control and 92%
intervention) at 8 weeks and 88% (93% of control and
85% of intervention) at 26 weeks. Eleven patients died
and 16 withdrew during the study period (Figure 1).
Characteristics for the intervention and control groups
were similar at baseline (Table 1). The mean age of the
sample was 57 years, and 61% were male. Both groups
had a median ICU length of stay of 6 days and median
hospital length of stay of 18.5 days. The overall median
period of mechanical ventilation was 90 hours, with a
mean Day 1 APACHE II score of 19.5. Fifty-five percent
of participants had a non-operative diagnosis. The most
prevalent APACHE III diagnostic groups on admission
were gastrointestinal (30%), respiratory (24%) and cardi-
ovascular (20%), with 8% sepsis and 6% trauma diag-
noses. The baseline (Week 1) mean norm-based PF
scores were 27.1 and 28.8 for the intervention and con-
trol groups respectively, and the 6MWT distance was
291 and 324 metres (Table 1). Physical functioning at
baseline did not differ significantly between those with
complete and incomplete data (P = 0.86).
There were no significant group effects or group by
time interactions (see Table 2) for PF, and no significant
covariates after adjusting for baseline PF. This was also
the case for 6MWT, MCS and PCS (Table 2). The time
effect was significant for PF (P = 0.034) and 6MWT (P
= 0.0003), but not for PCS (P = 0.06) or MCS (P =
0.97). Both control and intervention groups showed
similar improvements between Week 1 and Week 8,
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the PCS and MCS (see Table 3). Clinically important
change scores of 12 (control) and 13 (intervention) for
the mean PF were noted at eight weeks. The change
scores between weeks 1 to 26 were 14 and 15
respectively, with little additional improvement from the
eight-week assessment. Oth e rd o m a i n sf o rS F - 3 6w e r e
also comparable between groups at all time points
(Table 4 details the domain scores for the two groups).
Change scores for 6MWT distance were 80 and 89
 
 
Satisfied inclusion criteria (n = 5980)  
   ≥  18 years old  
  ≥     48 hours ICU length of stay  
  ≥    24 hours mechanical ventilation 
Excluded (n = 5655)  
¾  Not discharged home (n = 198)  
¾  Living  >  50km away (n = 1652)  
¾  Organized rehabilitation (n = 846)  
¾  Neurological / spinal dysfunction (n = 1084)  
¾  Insuﬃcient English (n = 170)  
¾  Palliative care / not expected to survive (n = 967)  
¾  History of mental illness / noncompliance (n = 299)  
¾  Other (n = 438)  
 
Declined: (n = 130)  
Randomised 
(n = 195)  
Allocated (n = 98)   Allocated (n = 97) 
Week 1 (baseline) assessment  
Responded (n = 92)  
Withdrawal (n = 3)  
Lost to follow-up (n = 1)  
Died (n = 1)  
Intervention  Control  
Week 1 (baseline) assessment  
Responded (n = 91)  
Withdrawal (n = 6)  
Lost to follow-up (n = 0)  
Died (n = 1)  
183  
173  
161  
Week 8 assessment  
Responded (n = 85)  
Withdrawal (n = 3)  
Lost to follow-up (n = 2)  
Died (n = 2)  
Week 8 assessment  
Responded (n = 88)  
Withdrawal (n = 0)  
Lost to follow-up (n = 1)  
Died (n = 2)  
Week 26 assessment  
Responded (n = 76)  
Withdrawal (n = 2)  
Lost to follow-up (n = 2)  
Died (n = 5)  
Week 26 assessment  
Responded (n = 85)  
Withdrawal (n = 2)  
Lost to follow-up (n = 1)  
Died (n = 0)  
Figure 1 Consort flow diagram of patient recruitment and retention.
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Page 5 of 10metres at 8 weeks, and 116 and 126 metres at 26 weeks,
for the control and intervention groups respectively
(Table 3). Effect sizes for the impact of the intervention
were very small for all measures at 8 and 26 weeks
(Table 3), consistent with the mixed linear regression
models (Table 2). Discussion
Major findings
Our main findings were that this home-based rehabilita-
tion intervention had no significant effect on physical
Table 1 Sample baseline characteristics
Variable Control
(n = 91)
Intervention
(n = 92)
Age mean (sd) 57.5 (15.1) 57.2 (17.0)
Gender % M: 61 M: 62
APACHE II mean (sd) 19.5 (7.2) 19.4 (12.6)
MV hours mean (sd) 135 (117) 142 (159)
median
c (IQR) 91 (48-179) 76 (41-180)
ICU LOS days mean (sd) 8.6 (7.5) 9.4 (8.7)
median (IQR) 6 (4-10.5) 6 (4-11)
Hospital LOS days mean (sd) 23.2 (16.9) 24.8 (20.4)
median (IQR) 18.5 (12-27.5) 18.5 (12-30)
SF-36 PF
a mean (sd) 28.8 (10.2) 27.1 (12.3)
6MWT distance metres
a mean (sd) 324 (143) 291 (129)
SF-36 PCS
b mean (sd) 32.7 (8.6) 31.7 (10.0)
SF-36 MCS
b mean (sd) 39.8 (13.5) 36.7 (15.1)
APACHE, acute physiology and chronic health evaluation; LOS, length of stay;
MCS, mental components summary; MV, mechanical ventilation hours; PCS,
physical components summary
aMeasured at one week post-hospital discharge
bNorm-based score; Australian normative population mean = 50; standard
deviation = 10
cMedians included only for those variables with skewed distributions
Table 2 Mixed linear regression model: mean outcomes
adjusted for Week 1 (baseline) levels
Outcome Week Control Treatment P-value
Physical functioning 8 41.0 39.9 Group0.84
26 41.8 42.6 Time0.034
Group × time
0.68
Six Minute Walk Test
distance
8 395.6 402.5 Group0.92
26 431.4 428.3 Time0.0003
Group × time
0.55
Physical component
summary
8 42.5 40.7 Group0.39
26 43.2 42.7 Time0.06
Group × time
0.37
Mental component
summary
8 47.1 46.9 Group0.95
26 47.0 47.0 Time0.97
Group × time
0.89
Table 3 Mean change from baseline and effect size at 8
and 26 weeks following discharge
Control
(95% CI)
Effect
Size
a
Intervention
(95% CI)
Effect
Size
a
Difference
(95% CI)
Effect
Size
b
8 weeks
PF
d 12.2
(9.9,14.5)
1.17 12.9
(10.7,15.1)
1.02 0.7
(-2.5,3.8)
0.07
6MWT 80.3
(52.3,108.3)
0.55 88.7
(62.6,114.8)
0.69 8.4 (-29.6,
46.4)
0.07
PCS
c 9.9 (7.6,12.2) 1.10 8.6 (6.6,10.5) 0.87 -1.3 (-4.3,
1.7)
-0.14
MCS
c 7.8 (4.8,10.9) 0.59 9.7 (6.4,12.9) 0.66 1.8 (-2.6,
6.2)
0.13
26 weeks
PF 13.7
(11.4,16.0)
1.32 14.6
(11.7,17.6)
1.16 0.9 (-2.7,
4.6)
0.08
6MWT 116.2
(85.6,146.8)
0.80 125.8
(98.7,152.9)
0.98 9.6 (-31.4,
50.5)
0.08
PCS
c 10.6
(8.4,12.8)
1.18 10.9
(8.2,13.6)
1.11 0.3 (-3.2,
3.7)
0.03
MCS
c 8.1 (5.0,11.2) 0.61 9.6 (6.1,13.1) 0.65 1.5 (-3.1,
6.2)
0.10
6MWT, six minute walk test distance (metres); CI, confidence interval; MCS,
mental component summary; PCS, physical component summary; PF, physical
functioning
aEffect size = mean change from baseline/standard deviation at baseline
bEffect size = (Intervention mean change-Control mean change)/ pooled
standard deviation for change
cNorm-based score for Australian normative population mean = 50, standard
deviation = 10.
Table 4 Mean norm-based
aSF-36 scores by assessment
time point and group
SF-36 Domains Week 1 Week 8 Week 26
Groups C I C I C I
Physical function 29.1 27.3 41.0 39.9 41.8 42.6
Role function-physical 25.5 25.1 38.0 38.2 40.9 42.1
Bodily pain 43.0 38.7 49.0 46.7 46.9 44.5
General health 43.5 41.7 46.0 44.7 45.3 44.8
Vitality 38.1 36.0 46.9 45.5 47.0 47.6
Social function 30.1 27.9 44.9 43.0 44.5 44.5
Role function-emotional 32.0 28.0 42.4 41.1 42.9 43.6
Mental health 43.4 40.1 48.2 48.0 48.1 48.4
Physical component Summary 33.0 31.6 42.7 40.5 42.9 42.8
Mental component summary 40.0 36.6 47.5 46.9 47.2 48.0
C, control; I, intervention.
aNorm-based scores for domain and summary scores are calculated from raw
scores using population-based data for the Australian population; scores are
interpreted in relation to a population mean of 50 and a standard deviation
of 10.
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icant improvements over time, particularly during the
first eight weeks post-hospital discharge. Both groups
improved their physical endurance and HRQOL with a
similar trajectory at 8 and 26 weeks.
Possible reasons for lack of difference between the
groups were: 1) Natural recovery in this cohort over-
whelmed any differences afforded by training; 2) Lack of
compliance by intervention group participants, as exer-
cise training was unsupervised except for three occa-
sions during the eight weeks; 3) Prospective
measurement of the control group at 8 and 26 weeks
may have influenced outcomes by encouraging partici-
pation in exercise; 4) Training intensity was not ade-
quate, although this was unlikely given that this was
individualised, based on 6MWT results and progressed
as able. Even at eight weeks the 6MWD was only
approximately 408 metres suggesting that using 6MWD
as a way of prescribing intensity was still adequate. Had
the 6MWD been near to predicted normal (600 m) this
might have suggested that other means of exercise train-
ing where intensity could be higher, for example, run-
ning and treadmill exercise, would have been required.
Some of these issues are discussed in the ‘study limita-
tions’ below.
This sample of survivors of a critical illness was
broadly representative of the 83,000 patients admitted to
public-sector general adult ICUs in Australia each year,
in terms of APACHE II score (19.5 vs 15) and mechani-
cal ventilation hours (91 vs 71), with our study inclusion
criteria of ≥48 hours of ICU admission and ≥24 hours
of mechanical ventilation probably accounting for these
differences. (An additional 36,000 adults are admitted to
ICUs in private hospitals but their clinical profile is dif-
ferent (APACHE II = 13; median mechanical ventilation
hours = 44; ICU mortality = 2.7% vs 7.5%) [1]). The
mortality rate for study participants at six months was
6% (11/183), within our ap r i o r iexpectations of 10%,
although we have no data on those participants who
withdrew prior to (n = 12) or after the Week 1 assess-
ment (n = 16) or were lost to follow-up (n = 7).
A recent systematic review [38] of 53 observational
studies noted decreased HRQOL in survivors of a criti-
cal illness compared to age and gender-matched popula-
tions. In relation to other intervention studies from the
United Kingdom, our participants at Week 1 and Week
26 were remarkably similar to a recent equivalent ran-
domised clinical trial of nurse-led ICU follow-up clinics
in three hospitals (median age = 57 years; 60% males;
APACHE II = 19; ICU LOS was higher in our study, six
vs. three days; mechanical ventilation hours not
reported) [14]. Their intervention also included a man-
ual-based, self-directed physical rehabilitation program
from in-hospital to three months post-hospital
discharge, and clinic appointments at three and nine
months. The PCS at Week 1 was 32 in our study, com-
pared to 33 (n = 286) in the U.K. study. At week 26, the
P C Si no u rs t u d yw a s4 3 ,c o m p a r e dt o4 0( n =2 2 0 ) .
Interestingly, this trial also did not demonstrate an
intervention effect, and noted the possible reasons for
this null finding as an ineffective intervention package,
timing of the first intervention, no account for cognitive
factors that may influence recovery, or too broad an
inclusion criteria (particularly in relation to ICU LOS)
[14].
In contrast, an earlier study of a six-week self-help
rehabilitation manual with phone follow-up compared
to usual care (ward visits, three post-discharge phone-
calls, and ICU follow-up clinics at eight weeks and six
months), demonstrated an effect on the PF at six
months; scores for the control and intervention groups
were 40 and 50 respectively (n = 44 and 58) [15]. These
scores for the control group were again similar to our
findings of approximately 42 for both groups. Only
modest improvements on the PF were also noted from
eight weeks to six months [15], again similar to our
findings from 8 to 26 weeks. Neither of these two stu-
dies assessed walk function.
Overall, participants from both the control and inter-
vention groups improved their 6MWT distance by 27%
at 8 weeks and 39% at 26 weeks from the Week 1
assessments. These improvements of 89 and 120 metres
compared favourably with increases from pulmonary
rehabilitation programs for patients with moderate-
severe lung disease (35 metres; 10% improvement) [17]
and diffuse lung disease (34 metres) [39]. In an observa-
tional study of ARDS patients (n = 109), a median
6MWT distance of 396 metres at six months (n =7 8 ;
APACHE II = 23; ICU LOS = 25 days; mechanical ven-
tilation = 21 days) compared favourably to the 430
metres in our sample of less sick patients [40].
The eight-week intervention of three home visits for
at least one hour of supervised training, four telephone
follow-ups, and an expected two to three unsupervised
participant training sessions per week for the eight-week
program was consistent with studies of COPD patients
[41,42]. Recent clinical practice guidelines recommend
high-intensity aerobic training (60 to 80% of peak effort)
and strength training for COPD patients [43].
A small RCT of early physical therapy in ICU in com-
bination with daily interruption of sedation demon-
strated that the intervention group participants were 2.7
times more likely to return to independent functional
status at hospital discharge. Median walking distance at
hospital discharge for the intervention group (n = 49)
was 33 metres (range 0 to 91 m), compared to 0 metres
(0 to 30 m) for the control group (n = 55) [44]. Findings
from a current single-site randomised study of a post-
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anticipated to add further understanding to the effect of
these types of interventions on function across the con-
tinuum of recovery [45].
A recent systematic review of 12 RCTs of cardiac
rehabilitation noted superior adherence to a home-based
program, with centre-based programs having sub-opti-
mal participation because of access, dislike of groups
and other commitments [16]. However, others have
noted that an individually tailored exercise level was not
sufficient to influence functional outcomes in hospita-
lised acute medical patients aged 65 years or older [46].
The burden for survivors of a critical illness has been
well documented in many observational studies, where
the recovery trajectory is often prolonged and sub-opti-
mal [4]. Intervention studies with this clinical cohort
are, however, less common. To our knowledge this was
the first study internationally to use a home-based reha-
bilitation program with trainer visits in this patient
group. An individualised, home-based program negates
the need to attend an outpatient clinic located in a hos-
pital on a regular basis. This is particularly important
for individuals who reside in regional or rural areas but
were treated in a metropolitan ICU, as well as those
who choose not to or are unable to participate in hospi-
tal-based programs for other reasons such as lack of
mobility. The provision of a program through local
community health services would allow survivors of a
critical illness to engage in the program regardless of
place of residence and other mobility and access
constraints.
Study limitations
A number of limitations are noted. Although based on
previous equivalent work [15], our hypothesised treat-
ment ‘effect’ of a 10-point difference in the PF was opti-
mistic, with no clinically or functionally important
differences noted between groups at either post-inter-
vention measurement; both groups improved by an
average 12 points at eight weeks (not 5 and 15 points
for the control and intervention groups, respectively).
Effectiveness of the rehabilitation program may be
improved by increasing the intensity, frequency and
training support, but this requires further investigation,
particularly in relation to participant safety in a home-
based context. Importantly and similar to an earlier
study, [14] our collective knowledge of physical rehabili-
tation in this cohort has advanced significantly since we
designed our intervention, including a recent focus on
in-ICU mobility [for example 47, 48, 49, 50].
Our target recruitment sample of 240 was not
achieved despite screening almost 6,000 patients over 39
months, including a 12-month extension of the project
from the grant funding body and inclusion of additional
recruitment sites (recruitment ceased because of time-
frame and funding constraints). Our screening data
n o t e das i g n i f i c a n tp r o p o r t i o n( 2 8 % )o fp a t i e n t s
admitted to the city-based recruitment ICUs resided
outside metropolitan areas. Following analysis, and as
noted above, the effect size and resulting sample size
calculations were too small.
As detailed in Figure 1, large numbers of patients were
excluded from this study. Approximately half of these
exclusions were due to the patient not being suitable for
rehabilitation (for example, palliative care), or having a
condition that required different rehabilitation (for
example, neurological dysfunction or cardiac disease
where rehabilitation was provided). Some of the exclu-
sions were the result of limitations of a research setting
(for example, living too far away from a study hospital),
and these individuals could benefit if an effective inter-
vention is able to be identified.
The three assessment visits for the control group were
in addition to ‘usual care’. While this contact was una-
voidable and may have had a placebo effect, any effect
would reduce the apparent effectiveness of the interven-
tion. The treatment effect was therefore measured rela-
tive to the control group in the study, while in practice
the comparator would be usual care without assessment
contact. Measurement of physical activity in a trial can
also influence participant behaviour [51]. We have no
way of knowing how participants in our control group
responded to their 6MWT assessments, possibly chan-
ging their physical activity behaviour.
We were unable to objectively assess the compliance
of training for the intervention group, and relied on
self-reports of participants during trainer home visits
and follow-up phone calls. Finally, given that we demon-
strated no added effectiveness from the intervention
compared to the control, the lack of an economic eva-
luation was of no practical consequence.
Implications for practice
From a practice perspective, the benefits of a systematic
approach and equitable access to post-ICU rehabilitation
services remains unclear for facilitating the recovery of
survivors to their optimal physical, psychological and
social function. While not demonstrating effectiveness
of the intervention, actual delivery of this home-based
program was feasible for participants and trainers. If an
effective intervention can be identified, then using a
home-based approach may be of value for some indivi-
duals unable to attend hospital outpatient clinics
because of location, travel limitations or other reasons.
Recommendations for future research
Future research should explore strategies to increase the
effect size of any proposed intervention, and implement
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who would benefit most from a rehabilitation program;
that is those with demonstrated functional weakness or
impairment.
Conclusions
This study used a multi-centre randomised controlled
trial design to examine the efficacy of a novel applica-
tion of physical rehabilitation practices to an important
but often heterogeneous group of patients-survivors of a
critical illness. The study addressed outcomes that are
meaningful for patients and society-functional ability
and well-being following a critical illness, and also tar-
geted a health problem that is likely to increase as the
population ages, contributing to an area in which there
are currently minimal rigorous intervention studies.
While these null findings noted no significant effect
on physical recovery when compared to improvement
over time, the results do provide a baseline to further
develop and test interventions aimed at improving the
recovery trajectories for survivors of a critical illness.
Key messages
￿ Reviews of observational studies confirm significant
physical and psychological sequelae for a substantial
proportion of critical illness survivors.
￿ There a re mixed findings from the limited num-
ber of intervention studies that tested the effective-
ness of physical rehabilitation programs for survivors
of a critical illness, and no studies have tested a
home-based program using trainer visits.
￿ This study demonstrated that a home-based physi-
cal rehabilitation program was no more effective
than usual care in improving physical function or
health-related quality of life for survivors of a critical
illness at 6 months following hospital discharge.
￿ Further work is required to improve the effect of
any interventions for survivors of a critical illness.
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